“Rise of Personalized Medicine in Epilepsy Treatment”
- The epilepsy treatment market is increasingly embracing personalized medicine by tailoring therapies based on individual genetic makeup and seizure characteristics
- Genetic testing is now used to predict patient response to medications such as sodium channel blockers, helping reduce side effects and improve treatment efficiency
- Diagnostic tools such as neuroimaging and biomarkers are enhancing treatment precision by identifying specific seizure origins and underlying neurological variations
- For instance, patients with SCN1A gene mutations can benefit more from adjusted doses or alternative medications rather than standard drug protocols
- For instance, the deployment of responsive neurostimulation systems that detect seizure activity in real time and deliver targeted electrical pulses, especially in cases resistant to conventional therapies
- For instance, patients with SCN1A gene mutations can benefit more from adjusted doses or alternative medications rather than standard drug protocols
